Elekta AB Income from Continuous Operations 2013-2025 | EKTAY
Elekta AB income from continuous operations from 2013 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
| Elekta AB Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024 | $123 |
| 2023 | $90 |
| 2022 | $130 |
| 2021 | $143 |
| 2020 | $113 |
| 2019 | $133 |
| 2018 | $132 |
| 2017 | $14 |
| 2016 | $17 |
| 2015 | $75 |
| 2014 | $166 |
| 2013 | $203 |
| 2012 | $186 |
| Elekta AB Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2025-01-31 | $31 |
| 2024-10-31 | $21 |
| 2024-07-31 | $7 |
| 2024-04-30 | $39 |
| 2024-01-31 | $29 |
| 2023-10-31 | $31 |
| 2023-07-31 | $22 |
| 2023-04-30 | $52 |
| 2023-01-31 | $21 |
| 2022-10-31 | $11 |
| 2022-07-31 | $6 |
| 2022-04-30 | $46 |
| 2022-01-31 | $25 |
| 2021-10-31 | $44 |
| 2021-07-31 | $15 |
| 2021-04-30 | $39 |
| 2021-01-31 | $38 |
| 2020-10-31 | $43 |
| 2020-07-31 | $23 |
| 2020-04-30 | $42 |
| 2020-01-31 | $32 |
| 2019-10-31 | $23 |
| 2019-07-31 | $16 |
| 2019-04-30 | $59 |
| 2019-01-31 | $24 |
| 2018-10-31 | $32 |
| 2018-07-31 | $19 |
| 2018-04-30 | $65 |
| 2018-01-31 | $37 |
| 2017-10-31 | $31 |
| 2017-07-31 | $0 |
| 2017-04-30 | $11 |
| 2017-01-31 | $5 |
| 2016-10-31 | $6 |
| 2016-07-31 | $-8 |
| 2016-04-30 | $10 |
| 2016-01-31 | $1 |
| 2015-10-31 | $22 |
| 2015-07-31 | $-16 |
| 2015-04-30 | $40 |
| 2015-01-31 | $18 |
| 2014-10-31 | $27 |
| 2014-07-31 | $-20 |
| 2014-04-30 | $119 |
| 2014-01-31 | $22 |
| 2013-10-31 | $29 |
| 2013-07-31 | $-1 |
| 2013-04-30 | $128 |
| 2013-01-31 | $35 |
| 2012-10-31 | $38 |
| 2012-07-31 | $2 |
| 2012-04-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $1.949B | $1.704B |
| Elekta AB is a human care company engaged in developing and selling clinical solutions for the treatment of cancer and neurological diseases. It develops tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. The Company's offering is divided into five areas: Neuroscience, Oncology, Software, Brachytherapy and Services. Elekta AB is headquartered in Stockholm, Sweden. | |||